Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者
治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病
发生迹象。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者
治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病
发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床本采集和运输不当造
本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计
,以监测骨髓发育不良
继发性白血病的发生
。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂
治疗应该每年接受全
细胞计数检查,以监
发育不良
继发性白
发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗
年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年
血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床集和运输不当造成的
质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年
血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床集和运输不当造成的
质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表软件的观点;若发现问题,欢迎向我们指正。